Home > Insider Trading > Filing (0000899243-17-027189)

Filing Details

Accession Number:: 0000899243-17-027189
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-11-21 19:16:19
Reporting Period:: 2017-11-21

Accepted Time:: 2017-11-21 19:16:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604950	Scpharmaceuticals Inc.	SCPH	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1219014	M Scott Rocklage	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1240357	D John Diekman	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1589314	5Am Partners Iv, Llc	C/O Scpharmaceuticals Inc 2400 District Avenue Suite 310 Burlington MA 01830	No	No	Yes	No
1589315	5Am Ventures Iv, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1593361	5Am Co-Investors Iv, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1598549	J. Andrew Schwab	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-21	1,483,107	$0.00	1,483,107	No	4	C	Indirect	by 5AM Ventures IV, L.P.
Common Stock	Acquisiton	2017-11-21	1,011,623	$0.00	2,494,730	No	4	C	Indirect	by 5AM Ventures IV, L.P.
Common Stock	Acquisiton	2017-11-21	628,572	$14.00	3,123,302	No	4	P	Indirect	by 5AM Ventures IV, L.P.
Common Stock	Acquisiton	2017-11-21	61,795	$0.00	61,795	No	4	C	Indirect	by 5AM Co-Investors IV, L.P.
Common Stock	Acquisiton	2017-11-21	42,150	$0.00	103,945	No	4	C	Indirect	by 5AM Co-Investors IV, L.P.
Common Stock	Acquisiton	2017-11-21	26,190	$14.00	130,135	No	4	P	Indirect	by 5AM Co-InvestorsIV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	by 5AM Ventures IV, L.P.
No	4	C	Indirect	by 5AM Ventures IV, L.P.
No	4	P	Indirect	by 5AM Ventures IV, L.P.
No	4	C	Indirect	by 5AM Co-Investors IV, L.P.
No	4	C	Indirect	by 5AM Co-Investors IV, L.P.
No	4	P	Indirect	by 5AM Co-InvestorsIV, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-11-21	10,649,003	$0.00	1,483,107	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-11-21	7,263,649	$0.00	1,011,623	$0.00
Common Stock	Series A Preferred Stock	Disposition	2017-11-21	443,708	$0.00	61,795	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-11-21	302,652	$0.00	42,150	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Represents the total number of shares of Common Stock received by 5AM Ventures IV, L.P., upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
5AM Partners IV, LLC is the general partner of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (the "5AM Funds"). Dr. John D. Diekman, Andrew J. Schwab, and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC. 5AM Partners IV, LLC may be deemed to have sole voting and investment power over the shares beneficially owned by the 5AM Funds. Dr. Diekman, Mr. Schwab, and Dr. Rocklage may be deemed to have shared voting and investment power over the shares beneficially by the 5AM Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaim beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
Represents the total number of shares of Common Stock received by 5AM Ventures IV, L.P., upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
Represents the total number of shares of Common Stock received by 5AM Co-Investors IV, L.P., upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
Represents the total number of shares of Common Stock received by 5AM Co-Investors IV, L.P., upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017 and had no expiration date.